Shannon N. Westin, MD, MPH | Authors


Results of the ENPAC Trial Shows Promise in Recurrent Endometroid Cancer

November 01, 2022

Shannon N. Westin, MD, MPH, discusses the promising results of the ENPAC trial that showed the effectiveness of adding enzalutamide to standard of care chemotherapy for patients with recurrent endometriod cancer.